Cadence Pharmaceuticals Financial Market Data
| Last Close 28-Aug-2008 |
$9.92 |
Price/ Sales Ratio |
-- |
| 52-Week High |
$15.70 |
Price/ Book Ratio |
7.38 |
| 52-Week Low |
$4.84 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
-- |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$380.5 |
Return on Assets |
(68.9%) |
| Shares Outstanding (mil.) |
38.4 |
Return on Equity |
(109.0%) |
| Dividend Rate |
-- |
Current Ratio |
3.05 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.35 |
| # of Institutional Holders |
58 |
% Owned by Institutions |
40.0% |
| Latest Short Interest Ratio |
7.04 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
0.0% |
0.0% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
